Surgery after chemo for recurrent ovarian cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether removing the recurrent ovarian tumor with surgery, after chemo has worked well, can help women whose cancer came back more than 6 months after their last platinum chemo. It's for a first recurrence only, and the tumor must be able to be completely removed by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- This is your first time the ovarian cancer has come back
- Your last platinum chemo kept the cancer away for at least 6 months
- The cancer got smaller, went away, or stayed stable with chemo after it came back (or your CA-125 level dropped by at least half)
- A surgeon believes the tumor can be completely removed with surgery
- You agree to give signed consent and share your data for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with recurrent ovarian cancer whose disease came back more than 6 months after platinum chemo. It tests whether removing the recurrent tumor with surgery (after more chemo) can help—even if surgery wasn't an option before.
This trial tests whether having a second surgery after initial treatment can help people with ovarian cancer that came back but still responds to platinum-based chemotherapy. It may offer another option to remove remaining tumors and delay further treatments.
This trial tests whether doing additional surgery to remove visible tumor (“secondary cytoreduction”) before chemotherapy helps compared with chemotherapy alone. It’s for ovarian (or related) cancer that came back after prior PARP inhibitor maintenance and platinum chemotherapy.
This trial looks at whether removing as much tumor as possible with surgery can help people whose ovarian/peritoneal/fallopian tube cancer comes back quickly after platinum chemotherapy. It targets cases where the recurrence is limited and may be safely removed, then compares outcomes to standard care.
This trial tests if laparoscopic surgery after 3-4 cycles of chemotherapy can help people with advanced epithelial ovarian cancer. It's for those whose tumors have shrunk enough after chemo and who are healthy enough for surgery.
This trial tests whether doing additional (“secondary”) tumor-removal surgery can help people with ovarian, fallopian tube, or primary peritoneal cancer that has returned after PARP inhibitor maintenance. It focuses on people whose cancer can likely be fully removed and who are considered good candidates for surgery and follow-up treatment.
Hear when a new Platinum-sensitive Ovarian Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.